Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576t mutation in the 23s rRNA gene in a tertiary-care hospital, Brazil

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 3, 2012, Pages 768-769

  de Almeida, Lara M ^a   Lincopan, Nilton ^a   de Araújo, Maria Rita E ^b   Mamizuka, Elsa M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

Ribosomal mutation; S. epidermidis; Staphylococci

Indexed keywords

AMIKACIN; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; PENICILLIN G; RIBOSOME PROTEIN; RIBOSOME RNA; SULBACTAM; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL MUTATION; BACTERIUM ISOLATE; BRAZIL; CLONE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCUS EPIDERMIDIS; TERTIARY HEALTH CARE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BRAZIL; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; OXAZOLIDINONES; POINT MUTATION; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84856966298     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr538     Document Type: Letter

References (8)

1. Leach KL, Swaney SM, Colca JR et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 2007; 26: 393-402.
2. Mendes RE, Deshpande LM, Farrell DJ et al. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother 2010; 65: 2329-35.
3. Miller K, Dunsmore CJ, Fishwick CW et al. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center. Antimicrob Agents Chemother 2008; 52: 1737-42.
4. Gales AC, Sader HS, Andrade SS et al. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Int J Antimicrob Agents 2006; 27: 300-2.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
6. Kehrenberg C, Schwarz S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 2006; 50: 1156-63.
7. Thomas JC, Vargas MR, Miragaia M et al. Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol 2007; 45: 616-9.
8. Liakopoulos A, Spiliopoulou I, Damani A et al. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother 2010; 65: 1070-1.